Pooled Safety Analysis of T-DM1 in HER2-Positive Metastatic Breast Cancer


Pooled Safety Analysis of T-DM1 in HER2-Positive Metastatic Breast Cancer
Slides from a presentation at SABCS 2012 and transcribed comments from an interview with Kimberly L Blackwell, MD (6/26/12)
Dieras V et al. Trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2-positive metastatic breast cancer: Pooled safety analysis. San Antonio Breast Cancer Symposium 2012;Abstract P5-18-06.

Dr Blackwell is Professor of Medicine and Director of the Breast Cancer Program at Duke Cancer Institute in Durham, North Carolina.